Inborn errors of STAT1 immunity.
Journal
Current opinion in immunology
ISSN: 1879-0372
Titre abrégé: Curr Opin Immunol
Pays: England
ID NLM: 8900118
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
24
12
2020
revised:
27
02
2021
accepted:
27
02
2021
pubmed:
12
4
2021
medline:
11
3
2022
entrez:
11
4
2021
Statut:
ppublish
Résumé
Signal transducer and activator of transcription 1 (STAT1) is a latent cytoplasmic transcription factor that is activated by multiple stimuli, including type I, II, and III interferons and interleukin-27. Inborn errors of human STAT1 immunity underlie 4 distinct disorders: autosomal recessive (AR) complete STAT1 deficiency, AR partial STAT1 deficiency, autosomal dominant (AD) STAT1 deficiency, and AD STAT1 gain-of-function. Each disease presents distinct clinical manifestations, excluding the difference in two AR STAT1 deficiencies, which are mainly explained by severity. This observation reflects the multiple and complex roles of STAT1 and how STAT1-mediated signaling is finely tuned in host immune systems.
Identifiants
pubmed: 33839590
pii: S0952-7915(21)00019-4
doi: 10.1016/j.coi.2021.02.009
pii:
doi:
Substances chimiques
STAT1 Transcription Factor
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
59-64Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.